Literature DB >> 26283267

Gene therapy. Inhibiting apoC-III synthesis in patients with hypertriglyceridaemia.

Karina Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26283267     DOI： 10.1038/nrcardio.2015.127

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

Authors:  Daniel Gaudet; Veronica J Alexander; Brenda F Baker; Diane Brisson; Karine Tremblay; Walter Singleton; Richard S Geary; Steven G Hughes; Nicholas J Viney; Mark J Graham; Rosanne M Crooke; Joseph L Witztum; John D Brunzell; John J P Kastelein
Journal:  N Engl J Med       Date:  2015-07-30       Impact factor: 91.245
  1 in total
  1 in total

1.  High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin.

Authors:  Oliviero Olivieri; Gianni Turcato; Manuel Cappellari; Filippo Stefanoni; Nicola Osti; Francesca Pizzolo; Simonetta Friso; Antonella Bassi; Annalisa Castagna; Nicola Martinelli
Journal:  Front Cardiovasc Med       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.